Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Takayasu's arteritis

K M Pariser1

  • 1Division of Rheumatology, Faulkner Hospital, Jamaica Plain, MA 02130.

Current Opinion in Cardiology
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Takayasu arteritis is a cell-mediated immune condition. New imaging and angioplasty techniques improve diagnosis and treatment, with prednisone and methotrexate showing promise for managing this rare disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Neuromusculoskeletal Modeling Pipeline: MATLAB-based Model Personalization and Treatment Optimization Functionality for OpenSim.

bioRxiv : the preprint server for biology·2024
Same author

Remitting, seronegative (A) symmetrical synovitis with pitting edema--two cases of RS3PE syndrome.

The Journal of rheumatology·1991
Same author

Demonstration of Borrelia burgdorferi in a patient with chronic Lyme arthritis.

Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology·1986
Same author

Borrelia burgdorferi in joint fluid in chronic Lyme arthritis.

Annals of internal medicine·1986
Same author

Nifedipine-induced fingertip vasodilation in patients with Raynaud's phenomenon.

American heart journal·1984
Same author

Nifedipine as a therapeutic modality for Raynaud's phenomenon.

Arthritis and rheumatism·1983
Same journal

An integrative approach to patient selection for mitral transcatheter edge-to-edge repair in secondary mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial.

Current opinion in cardiology·2026
Same journal

Advancements in wearable technology for heart failure patients.

Current opinion in cardiology·2026
Same journal

Minimally invasive approaches to coronary artery bypass grafting: techniques, current evidence, and future directions.

Current opinion in cardiology·2026
Same journal

Advances in artificial intelligence for the evaluation of mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Role of nutritional interventions to reduce cardiometabolic disease burden in the community.

Current opinion in cardiology·2026
See all related articles

Area of Science:

  • Immunology
  • Vascular Medicine
  • Rheumatology

Background:

  • Takayasu arteritis is an uncommon inflammatory condition affecting large arteries.
  • Recent advances suggest it's a cell-mediated immune disorder, though its exact cause remains unknown.
  • Improved diagnostic and therapeutic strategies are crucial for managing this rare disease.

Purpose of the Study:

  • To review current understanding of Takayasu arteritis.
  • To highlight advancements in diagnostic imaging and interventional procedures.
  • To discuss therapeutic approaches, including medical and interventional options.

Main Methods:

  • Review of current literature on Takayasu arteritis.
  • Discussion of advanced vascular imaging techniques (DSA, duplex ultrasonography, MRI).

Related Experiment Videos

  • Analysis of percutaneous transluminal angioplasty outcomes and medical management strategies.

    • Main Results:

    • Takayasu arteritis is increasingly recognized as a cell-mediated immune condition.
    • Advanced imaging improves diagnosis and management safety.
    • Percutaneous transluminal angioplasty offers short-term relief but restenosis is common.
    • Prednisone plus methotrexate shows promise for controlling inflammation.

    Conclusions:

    • Takayasu arteritis management benefits from improved imaging and interventional techniques.
    • Combination therapy with prednisone and methotrexate is a promising approach for this serious condition.
    • Further research is needed to clarify the long-term effects of angioplasty and the precise etiology of the disease.